Leading manufacturers such as Johnson & Johnson, Baxter, NIPRO Medical Corp., Olympus Medical Systems Group, W. L. Gore & Associates, Asahi Intecc, Edwards Lifesciences, Dexcom, Fujikura, Jabil Healthcare, and Maxim Integrated Ventures, and many others participate as application reviewers, mentors, and judges
In 2021, MedTech Innovator will hold competitions at the Wilson Sonsini Medical Device Conference in San Francisco, CA; and The MedTech Conference in Minneapolis, MN.
Providers like UCLA Health, Hackensack Meridien, Mayo Clinic, and Providence participate as application reviewers and judges and give critical feedback on topics like healthcare economics, customer requirements, integration issues, and more
Active investors like RCT Ventures, Aphelion Capital, Life Science Angels, Healthtech Capital, Band of Angels, and others participate as application reviewers, mentors, and judges
MedTech Innovator has partnered with AdvaMed and AdvaMed Accel in the US and APACMed in Asia to provide best-in-class start-ups access to a virtual accelerator and to support members developing innovative and transformational medical technologies.
Experts provide critical feedback to MedTech Innovator companies from leading service providers like Wilson Sonsini Goodrich & Rosati, EdgeOne Medical, Experien Group, Greenlight Guru, Medmarc, Proxima Clinical Research, Silicon Valley Bank, Westwood & Wilshire, and Ximedica.
Silicon Valley Bank’s CipherBio Q3 2020 Accelerator Insights report revealed for the first time that MedTech Innovator is the largest accelerator of Life Science companies in the world. The dominant part of our portfolio is Medical Devices, in addition to our leadership position as an accelerator of diagnostics and digital health technologies. 86% of our companies have raised equity financing, and our portfolio had more funding rounds in 2020 than any other accelerator. See the full report for these another other insights.
In 2021, MedTech Innovator and its partners will give out $500K+ in cash prizes as well as other awards in our US program. The competition includes several rounds where companies gain increasing amounts of exposure to industry leaders including through online application reviews, virtual pitch sessions, and audience competitions at several conferences.
MedTech Innovator Road Tour – Companies identified during the review process of being of strategic interest will be invited to pitch at one of our virtual pitch events in February – May. At each event, startups will have the opportunity to present and receive feedback from 45-60 judges including investors, providers, and senior executives from leading industry stakeholders such as Johnson & Johnson, Baxter, Olympus, Nipro, Edwards Life Sciences, Asahi Intecc, Maxim Intergrated, W.L. Gore, Dexcom, and many others. Based on feedback, companies may be selected to advance to participate in the MedTech Innovator Showcase and/or Accelerator Program.
MedTech Innovator Showcase – 50 companies will be selected from the MedTech Innovator Road Tour to the Showcase program which prominently features the most innovative companies from around the world each year at two leading industry conferences. Showcase companies receive coaching and high-profile visibility at the WSGR Medical Device conference in June and The MedTech Innovator Showcase program at The MedTech Conference, powered by AdvaMed, in September. Among many benefits, MedTech Innovator Showcase companies receive full conference scholarships, are featured in expert panels, and gain access to exclusive partnering and networking.
MedTech Innovator Accelerator – 25 companies will receive a place in the MedTech Innovator Accelerator, a 4-month virtual program from June – September. Accelerator companies have an unparalleled opportunity to receive continual in-depth, customized mentorship from senior leaders in the medtech industry. The accelerator commences with a Summit that includes exclusive networking, workshops, and pitching with investors, manufacturers, providers, and customers. All 25 Accelerator companies receive complimentary registration to the WSGR Medical Device Conference where they have opportunities to showcase their company and compete to present for a Value Award and a profile in the MedTech Strategist. The Accelerator program concludes with all 25 companies participating in the Accel Leadership Seminar, the MedTech Innovator Showcase, and an opportunity to compete to present in the finals at The MedTech Conference.
MedTech Innovator now offers a parallel competition and program providing content regarding accessing and operating in the Asia Pacific region in an Accelerator, Showcase and US$300K competition in front of industry leaders at the Asia Pacific MedTech Forum in the fall. Companies may apply to both our US-based and Asia programs. Please visit our MedTech Innovator Asia Pacific page for more information on our 2021 Asia Pacific program.
Paul is the founder and CEO of MedTech Innovator. He created and managed MedTech Innovator as a program within RCT Ventures from 2013 – 2016. In 2016, with the financial support of RCT and other sponsors, Paul left to run MedTech Innovator as a stand-alone company. He spent 11 years as Director and Managing Director at RCT Ventures, the investment arm of Research Corporation Technologies, Inc. Prior to RCT, Paul was co-founder and CEO of startups in the medtech, pharma, and tech sectors.
Kathryn Zavala is COO and BioTools Innovator Managing Director at MedTech Innovator. She earned her PhD in Molecular, Cell and Developmental Biology from UCLA. Kathryn has been with MedTech Innovator since 2015. She was a Technology Fellow at the UCLA Office of Intellectual Property, where she assisted with the commercialization of university technologies.
Brian Benson is the VP of Strategic Alliances at MedTech Innovator. Prior to joining MedTech Innovator, Brian was the director of entrepreneurship and commercialization at the California NanoSystems Institute (CNSI) where he was responsible for all aspects of the Magnify incubator and driving strategic initiatives for the Institute. He received his B.B.A. in Entrepreneurship from Loyola Marymount University. Brian brings over 10 years of experience accelerating the growth and success of transformative life science startups to the team.
Fredrik is the Managing Director Asia Pacific at MedTech Innovator, based in Singapore. He was most recently the Founding CEO of Asia Pacific Medical Technology Association (APACMed). Fredrik brings over 30 years of healthcare industry experience, 25 of which were spent in Asia-Pacific. He has held senior sales/ marketing, general management and strategic consulting positions. Fredrik serves as Board Member and advisor to several healthcare startup ventures and is a frequent speaker on the healthcare industry in Asia-Pacific. He holds a BSc from Gothenburg University, Sweden, and an MBA from Henley Management College, UK.
Sakeena is the Program Director Asia Pacific at MedTech Innovator, based in Singapore. She holds leadership and management consulting experiences from past roles as Regional Head of Program Management for Slush SEA, as well as a Life Sciences & Healthcare M&A Consultant in Deloitte APAC. As an entrepreneurial scientist, Sakeena was active in the tech ecosystem while donning a lab coat in the R&D industry specialising in Nutraceutical Research. She is passionate about bridging the translational gap between research science and entrepreneurship.
Ayelet Marom is the Program Director for BioTools Innovator at MedTech Innovator. She earned her Ph.D. in Cancer Immunology from The Weizmann Institute in Israel, and a Postdoctoral Professional Masters in Bioscience Management from KGI, Claremont alongside her post-doctoral research at City Of Hope. Ayelet is experienced in the innovation ecosystem; prior to MedTech Innovator, she was a senior program manager at Larta Institute, where she managed commercialization programs for science-based Innovations, as well as co-founded and led the product development in a digital health Startup. She is passionate about bringing technology and healthcare closer together to make a real impact on human health.
Jerry Ciolino is a Marketing & Events Associate at MedTech Innovator. He has experience working in multiple accelerator programs with different verticals. He was the Program Manager at Startup UCLA, which caters to undergraduates, graduate students, and recent alumni on the UCLA campus. More recently, he was the Lead Operations Associate for the Techstars Music Accelerator. He received his degree in Sociology from UCLA.
Yuni Kay is a Senior Fellow at MedTech Innovator. She is currently a PhD candidate in Neuroscience at USC. Prior to graduate school, she was a Postbac Fellow at the NIH. Yuni received her BA in Neuroscience from Pomona College.
Olivia Ellegard is a Marketing Intern at MedTech Innovator. She is a student at the University of Southern California pursuing bachelor degrees in Communications and Psychology as well as a Master’s degree in Healthcare Decision Analysis. She has experience working in talent management, public relations, social media, and research.
Cynthia (Cyn) McKee is a Ph.D. candidate at UCLA who is driven to identify gaps in science-based technologies and is passionate about mentoring research scientists in the art of business communication. When she is not working, Cynthia enjoys sailing off the coast of Catalina Island or cooking multicourse meals for family and friends.
Glen Meyerowitz is a graduate student in Electrical and Computer Engineering at UCLA and a UCLA Biodesign Fellow. He previously worked as an engineer at SpaceX, testing rocket and spacecraft propulsion systems and TuSimple, developing methods for safely implementing autonomous vehicle technology. He has experience translating and developing medical technology from the lab into products.
Eugene Yoon is a Fellow at MedTech Innovator. He became passionate about bridging the gap between science and entrepreneurship from work experience in a biotechnology startup. Eugene holds a BS in Chemical and Biomolecular Engineering from Johns Hopkins University, as well as a MS and soon a PhD in Biomedical Engineering from USC.
Scott Whitaker is President and CEO of AdvaMed, the world’s largest medical technology association.He is widely recognized as a top health care advocate and policy expert with experience across multiple health policy sectors, having worked successfully with diverse stakeholder groups – including hospital, patient and physician groups, regulators, public and private payers, and global trade organizations – to advance medical technology innovation and timely patient access to next-generation treatments and cures.
Chris Martin is the President of RCT Ventures, the investment arm of Research Corporation Technologies, which is focused on investing in early-stage biomedical companies.
Mr. Kessler has broad experience in finance, actively sourcing and identifying investment opportunities, and negotiating, structuring and re-structuring investment transactions with emerging growth public companies.
Casey McGlynn is a partner at Wilson Sonsini Goodrich & Rosati. In 1990, Casey McGlynn formed the life sciences practice at the firm, and today, it has one of the largest practices focused on medtech, healthtech, and biotech companies in the country.